FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2634411000001102: Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24914101000001113 Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54576601000001116 Moclobemide 150mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 2 x 15 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Is a Moclobemide 150mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Is pack of Moclobemide 150mg tablets (Unichem Plc) false Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has active ingredient Moclobemide false Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has AMP Moclobemide 150mg tablets (Unichem Plc) true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has specific active ingredient Moclobemide true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Unichem Plc) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start